Trials / Completed
CompletedNCT01883999
Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis
Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis for the Treatment of Common Iliac Artery Aneurysms or Aorto-iliac Aneurysms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- W.L.Gore & Associates · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The Iliac Branch Endoprosthesis (IBE) 12-04 study will be a prospective, nonrandomized, multicenter, single-arm evaluation designed to assess the safety and efficacy of the IBE Device in subjects with common iliac artery aneurysms (CIAA) or aorto-iliac aneurysms (AIA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GORE® EXCLUDER® Iliac Branch Endoprosthesis |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2016-04-01
- Completion
- 2021-06-01
- First posted
- 2013-06-21
- Last updated
- 2021-11-02
- Results posted
- 2016-08-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01883999. Inclusion in this directory is not an endorsement.